Wayfair To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Goldman Sa
BenzingaApr 4 07:40 ET
Asensus Surgical Cut to Neutral From Buy by HC Wainwright & Co.
Asensus Surgical Cut to Neutral From Buy by HC Wainwright & Co.
Dow JonesApr 4 06:17 ET
HC Wainwright & Co. Downgrades Asensus Surgical to Neutral, Lowers Price Target to $0.35
HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Asensus Surgical (AMEX:ASXC) from Buy to Neutral and lowers the price target from $2 to $0.35.
BenzingaApr 4 06:06 ET
Sector Update: Health Care Stocks Rise Wednesday Afternoon
Health care stocks were advancing Wednesday afternoon, with the NYSE Health Care Index adding 0.3% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%. The iShares Biotechnology ETF (IBB) decrea
MT NewswiresApr 3 13:54 ET
Asensus Surgical Agrees To Karl Storz's Acquisition Offer; Stock Up
RTTNewsApr 3 10:14 ET
Asensus Surgical Agrees to Enter Diligence After Takeover Offer
By Will Feuer Asensus Surgical said it has entered into a non-binding letter of intent with Karl Storz, medical-technology company, to engage in diligence and negotiations regarding a takeover offer.
WSJApr 3 09:16 ET
Express News | Asensus Surgical Enters Into Non-Binding Acquisition Proposal And Exclusivity Arrangement With KARL STORZ SE & Co; KARL STORZ' To Acquire 100% Of Issued And Outstanding Shares Of Stock For $0.35/Share In Cash
Moomoo 24/7Apr 3 08:47 ET
Press Release: Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement With KARL STORZ SE & Co. KG
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG KARL STORZ to provide up to $20 million in bridge financing RESEARCH TRIANGL
Dow JonesApr 3 08:45 ET
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement With KARL STORZ SE & Co. KG
KARL STORZ to provide up to $20 million in bridge financingRESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) ("Asensus" or the "Company"),
Asensus SurgicalApr 3 00:00 ET
Asensus Surgical Is Maintained at Buy by HC Wainwright & Co.
Asensus Surgical Is Maintained at Buy by HC Wainwright & Co.
Dow JonesMar 22 11:13 ET
Express News | HC Wainwright & Co. Maintains Buy on Asensus Surgical, Maintains $2 Price Target
Moomoo 24/7Mar 22 11:02 ET
Asensus Surgical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/22/2024 703.21% HC Wainwright & Co. $2 → $2 Maintains Buy 11/16/2023 — Cantor Fitzgerald Downgrades Ov
BenzingaMar 22 11:01 ET
Buy Rating Affirmed on Asensus Surgical Amidst Growth and Expansion Prospects
TipRanksMar 22 08:45 ET
Earnings Call Summary | Asensus Surgical(ASXC.US) Q4 2023 Earnings Conference
The following is a summary of the Asensus Surgical, Inc. (ASXC) Q4 2023 Earnings Call Transcript:Financial Performance:Asensus reported a Q4 revenue of $5.4 million, a significant increase from $2.5 m
moomoo AIMar 21 19:19 ET · Conference Call
Recap: Asensus Surgical Q4 Earnings
Asensus Surgical (AMEX:ASXC) reported its Q4 earnings results on Thursday, March 21, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsAsensus Surgical beat estimated
BenzingaMar 21 16:20 ET
Asensus Surgical Intends to File Annual Report on Form 10-K on or About March 21 >ASXC
Asensus Surgical Intends to File Annual Report on Form 10-K on or About March 21 >ASXC
Dow JonesMar 21 16:17 ET
Asensus Surgical: Audited Fincl Statements Will Contain Going Concern Paragraph >ASXC
Asensus Surgical: Audited Fincl Statements Will Contain Going Concern Paragraph >ASXC
Dow JonesMar 21 16:16 ET
Asensus Surgical Anticipates Available Cash Will Now Sustain Ops Until Early June
Asensus Surgical Anticipates Available Cash Will Now Sustain Ops Until Early June
Dow JonesMar 21 16:15 ET
Asensus Surgical Expects to Initiate 8 - 10 New Senhance Programs in 2024 >ASXC
Asensus Surgical Expects to Initiate 8 - 10 New Senhance Programs in 2024 >ASXC
Dow JonesMar 21 16:14 ET
Asensus Surgical Non-GAAP EPS of -$0.07 Misses by $0.02, Revenue of $5.43M Misses by $0.04M
Seeking AlphaMar 21 16:10 ET
No Data
No Data